References
- American Psychiatric AssociationDiagnostic and statistical manual of mental disorders, IVth edn, Text Revision (DSM-IV-TR)2000Washington, DCAmerican Psychiatric Association
- AsnisGMHameediFAGoddardAWFluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatientsPsychiatry Res200110311411472786
- BakishDHooperCLFilteauMJA double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobiaPsychopharmacoly Bull19963213541
- BakishDSaxenaBMBowenRReversible monoamine oxidase-A inhibitors in panic disorderClin Neuropharmacology1993167782
- BakkerAvan BalkomAJSpinhovenPSSRIs vs TCAs in the treatment of panic disorder: a meta-analysisActa Psychiatrica Scand20021061637
- BallengerJCWheadonDESteinerMDouble-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorderAm J Psychiatry199815536429433336
- BandelowBBehnkeKLenoirSSertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparisonJ Clin Psychiatry2004654051315096081
- BlackDWWesnerRBowersWA comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorderArch Gen Psychiatry19935044508422221
- BotellaCVillaHGarcia-PalaciosARivaGBotellaCLégeronPOptaleGThe use of virtual reality in the treatment of panic and agoraphobiaCybertherapy: Internet and virtual reality as assessment and rehabilitation tools for clinical psychology and neuroscience2004aAmsterdamIos Press
- BotellaCVillaHGarcia PalaciosAThe use of VR in the treatment of panic disorders and agoraphobiaStud Health Techn Informatics2004b997390
- BradwejnJAhokasASteinDJVenlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled studyBr J Psychiatry2005187352916199795
- BruceSEVasileRGGoismanRMAre benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?Am J Psychiatry200316014323812900305
- ButlerACChapmanJEFormanEMThe empirical status of cognitive-behavioural therapy: a review of meta-analysesClin Psychol Rev200626173116199119
- CarlbringPBohmanSBruntSRemote treatment of panic disorder: a randomized trial of internet-based cognitive behavior therapy supplemented with telephone callsAm J Psychiatry200616321192517151163
- ChouinardGIssues in the clinical use of benzodiazepines: potency, withdrawal, and reboundJ Clin Psychiatry20046571215078112
- CraskeMGFarchioneTJAllenLBCognitive behavioural therapy for panic disorder and comorbidity: More of the same or less of more?Behav Res Ther200645109510917069753
- DannonPNIancuICohenAThree year naturalistic outcome study of panic disorder patients treated with paroxetineBMC Psychiatry200441615191617
- FavaGARuiniCRafanelliCSequential treatment of mood and anxiety disordersJ Clin Psychiatry200566139240016420076
- FurukawaTAWatanabeNChurchillRPsychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic reviewBr J Psychiatry20061883051216582055
- GouldRAOttoMWPollackMHA meta-analysis of treatment outcome for panic disorderClin Psychol Review19951581944
- HeldtEGus ManfroGKipperLOne-year follow-up of pharmacotherapy-resistant patients with panic disorder treated with cognitive-behavior therapy: Outcome and predictors of remissionBehav Res Therapy20064465765
- Hoehn-SaricRMcLeodDRHipsleyPAEffect of fluvoxamine on panic disorderJ Clin Psychopharmacology1993133216
- KampmanMKeijsersGPJHoogduinCALA randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioural therapy aloneJ Clin Psychiatry200263772712363116
- KatonWRussoJSherbourneCIncremental cost-effectiveness of a collaborative care intervention for panic disorderPsychological Medicine2006363536316403243
- KesslerRCChiuWTJinRThe epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey ReplicationArch Gen Psychiatry200663415416585471
- KleinDFDelineation of two drug-responsive anxiety syndromesPsychopharmacologia1964539740814194683
- KrugerMBDahlAAThe efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorderEur Arch Psych Clin Neurosciences19992491924
- LecrubierYBakkerADunbarGA comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study InvestigatorsActa Psychiatr Scand199795145529065680
- LecrubierYJudgeRLong-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study InvestigatorsActa Psychiatr Scand199795153609065681
- LepolaUMWadeAGLeinonenEVA controlled, prospective, 1-year trial of citalopram in the treatment of panic disorderJ Clin Psychiatry199859528349818634
- LondborgPDWolkowRSmithWTSertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigationBr J Psychiatry199817354609850204
- MarcusSMGormanJShearMKA comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapyAm J Psychiatry2007164273517267790
- MavissakalianMRImipramine vs. sertraline in panic disorder: 24-week treatment completersAnn Clin Psychiatry2003151718014971862
- MavissakalianMRPerelJMLong-term maintenance and discontinuation of imipramine therapy in panic disorder with agoraphobiaArch Gen Psychiatry199956821712884888
- MavissakalianMRPerelJMDuration of imipramine therapy and relapse in panic disorder with agoraphobiaJ Clin Psychopharmacol200222294912006900
- MichelsonDAllgulanderCDantendorferKEfficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trialBr J Psychiatry2001179514811731354
- MichelsonDLydiardRBPollackMHOutcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study GroupAm J Psychiatry1998155157079812120
- MichelsonDPollackMLydiardRBContinuing treatment of panic disorder after acute response: randomised, placebo-controlled trial with fluoxetine. The Fluoxetine Panic Disorder Study GroupBr J Psychiatry1999174213810448445
- MitteKA meta-analysis of the efficacy of psycho-and pharmacotherapy in panic disorder with and without agoraphobiaJ Affect Disord200588274516005982
- OehrbergSChristiansenPEBehnkeKParoxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled studyBr J Psychiatry199516737497496647
- OttoMWPowersMSmitsJASDAdding cognitive-behavioural therapy to pharmacotherapy for panic disorder: issues and strategiesCNS Spectrums20059329
- PohlRBWolkowRMClaryCMSertraline in the treatment of panic disorder: a double-blind multicenter trialAm J Psychiatry19981551189959734541
- PollackMHLepolaUKoponenHA double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorderDepress Anxiety20072411416894619
- PollackMHOttoMWWorthingtonJJSertraline in the treatment of panic disorder: a flexible-dose multicenter trialArch Gen Psychiatry1998551010169819070
- PollackMHSimonNMWorthingtonJJCombined paroxetine and clonazepam treatment strategies compared to paroxetine monotherapy for panic disorderJ Psychopharmacology20031727682
- PollackMHWorthingtonJJ3rdOttoMWVenlafaxine for panic disorder: results from a double-blind, placebo-controlled studyPsychopharmacol Bull199632667708993089
- PullCBCottrauxJBerthozARandomized controlled study of virtual reality exposure therapy and cognitive-behaviour therapy in panic disorder with agoraphobiaCyberpsychol Behav20069712
- PullCBCurrent status of virtual reality exposure therapy in anxiety disorders: editorial reviewCurr Opin Psychiatry20051871416639177
- PullCBSelf-help interventions for the treatment of anxiety disordersCurr Opin Psychiatry20061950316612179
- PullCBCombined pharmacotherapy and cognitive-behavioural therapy for anxiety disordersCurr Opin Psychiatry20072030517143079
- ResslerKJRothbaumBOTannenbaumLCognitive Enhancers as Adjuncts to Psychotherapy. Use of D-Cycloserine in Phobic Individuals to Facilitate Extinction of FearArch Gen Psychiatry20046111364415520361
- RickelsKSchweizerEWeissSMaintenance drug treatment for panic disorder. II Short- and long-term outcome after drug taperArch Gen Psychiatry1993506188422223
- RiedererPLachenmayerLLauxGClinical applications of MAO-inhibitorsCurr Med Chem20041120334315279566
- RollmanBLBelnapBHMazumdarSA randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary careArch Gen Psychiatry20036213324116330721
- RosenbaumJFThe development of clonazepam as a psychotropic: the massachusetts general hospital experienceJ Clin Psychiatry2004653615078111
- Roy-ByrnePPCowleyDSNathanPGormanJMPharmacologic treatment for panic disorder, generalized anxiety disorder, specific phobia and social anxiety disordersA guide to treatments that work2002Second EditionNew YorkOxford University Press33765
- Roy-ByrnePPCraskeMGSteinMBA randomized effectiveness trial of cognitive-behavioural therapy and medication for primary care panic disorderArch Gen Psychiatry200562290815753242
- Roy-ByrnePPCraskeMGSteinMBPanic disorderLancet200636810233216980119
- SchweizerEPohlRBalonRLorazepam vs. alprazolam in the treatment of panic disorderPharmacopsychiatry1990239032187213
- SheehanDVBurnhamDBIyengarMKEfficacy and tolerability of controlled-release paroxetine in the treatment of panic disorderJ Clin Psychiatry200566344015669886
- SheikhJILondborgPClaryCMThe efficacy of sertraline in panic disorder: combined results from two fixed-dose studiesInt Clin Psychopharmacol2000153354211110009
- StahlSMGergelILiDEscitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trialJ Clin Psychiatry2003641322714658946
- TillerJWBouwerCBehnkeKMoclobemide and fluoxetine for panic disorder. International Panic Disorder Study GroupEur Arch Psych Clin Neurosciences1999249710
- ToniCPerugiGFrareFA prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressantsPharmacopsychiatry2000331213110958260
- Van VlietIMden BoerJAWestenbergHGA double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorderJ Clin Psychopharmacol1996162993068835705
- VersterJCVolkertsERClinical pharmacology, clinical efficacy, and behavioural toxicity of alprazolam: a review of the literatureCNS Drug Rev200410457614978513
- WadeAGLepolaUKoponenHJThe effect of citalopram in panic disorderBr J Psychiatry1997170549539330022
- WestenDMorrisonKA multidimensional meta-analysis of treatments for depression, panic, and generalized anxiety disorder: an empirical examination of the status of empirically supported therapiesJ Consult Clin Psychol2001698759911777114